Get started
Author

Ana Paula Neves Burian

Observed names: A. P. Neves Burian, A.P. Burian, A.P. Neves Burian, ANA PAULA BURIAN, ANA PAULA NEVES BURIAN, Ana Burian, Ana Paula Burian, Ana Paula N Burian, Ana Paula N. Burian, Burian, Ana Paula Neves
ORCID: 0000-0002-5056-5523
Observed ORCID: 0000-0002-5056-5523
OpenAlex ID: A5060422799
Planned Yellow Fever Primary Vaccination Is Safe and Immunogenic in Patients With Autoimmune Diseases: A Prospective Non-interventional Study
2020 · Valéria Valim, Ketty Lysie Libardi Lira Machado, et al. · Frontiers in Immunology · 32
PDF
Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort
2024 · Ketty Lysie Libardi Lira Machado, Ana Paula Neves Burian, et al. · Vaccines · 6
PDF
Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer
2024 · Vitor Alves Cruz, Camila Guimarães, et al. · Revista Brasileira de Reumatologia · 6
PDF
Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster dose
2023 · Maria da Penha Gomes Gouvea, Ketty Lysie Libardi Lira Machado, et al. · Vaccine · 6
Hospitalization due to pneumococcal disease in the Unified Health System in Brazil: A retrospective analysis of administrative data
2024 · Daniela V. Pachito, Mauricio Longato, et al. · The Brazilian Journal of Infectious Diseases · 5
Immunogenicity of SARS-CoV-2 Vaccination Schedules Including a Booster Dose in Patients with Systemic Lupus Erythematosus: Data from a Prospective Multicenter Study
2025 · Natalia Sarzi Sartori, Ketty Lysie Libardi Lira Machado, et al. · Vaccines · 4
PDF
Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination
2021 · Ismael Artur da Costa-Rocha, Ketty Lysie Libardi Lira Machado, et al. · Scientific Reports · 4
PDF
Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-Study
2024 · Debora Cerqueira Calderaro, Valéria Valim, et al. · Vaccines · 3
PDF
Previous biological therapy and impairment of the IFN-γ/IL-10 axis are associated with low immune response to 17DD-YF vaccination in patients with spondyloarthritis
2022 · Thays Zanon Casagrande, Ismael Artur da Costa-Rocha, et al. · Vaccine · 2
Real-world estimation of the pneumococcal vaccination coverage among high-risk population in the unified health system in Brazil: an administrative database analysis
2026 · Daniela V. Pachito, Paulo H.R.F. Almeida, et al. · Vaccine X · 1
Third Booster Half Dose of ChAdOx1-nCov-19 Is Effective, Safe, and Induces Long-Duration Humoral and Cellular Immune Response to Omicron: 1-Year Follow-Up of Viana Study
2025 · Nésio Medeiros-Junior, Maria Gouvea, et al. · Vaccines · 1
PDF
Hypersensitivity reactions to vaccines and immunization in patients with asthma: joint recommendations of the Brazilian Association of Allergy and Immunology and the Brazilian Immunization Society
2025 · Ana Karolina Barreto Berselli Marinho, Claudia França Cavalcante Valente, et al. · Arquivos de Asmas Alergia e Imunologia · 1
PDF
Projeto Curumim E Hesitação Vacinal Com Vacinas Contra Covid-19 Em Uma Coorte De Crianças E Adolescentes
2023 · Carolina Strauss Estevez, Kellen Christine Brites Gonçalves, et al. · The Brazilian Journal of Infectious Diseases · 1
AB1316 SAFETY AND IMMUNOGENICITY OF TWO HETEROLOGOUS VACCINE SCHEDULES AGAINST SARS-CoV-2 IN PATIENTS WITH RHEUMATOID ARTHRITIS: BRAZILIAN MULTICENTER STUDY
2023 · V. Cruz, K. Lysie Libardi Lira Machado, et al. · Annals of the Rheumatic Diseases · 1
PDF
Pos0271 Heterologous Covid-19 Booster Vaccination Produced Greater Antibody Titers in Autoimmune Disease Patients: Data From Multicentric Prospective Phase Iv Safer Study
2023 · K. Lysie Libardi Lira Machado, S. T. Miyamoto, et al. · Annals of the Rheumatic Diseases · 1
PDF
Vacinação Anti‐amarílica Em Pacientes Com Doenças Reumáticas Imunomediadas: Análise Retrospectiva
2017 · K.L.L. Lira, L. Balarini, et al. · Revista Brasileira de Reumatologia · 1
Immunogenicity and safety of BNT162b2 vaccine in patients with juvenile immune mediated inflammatory disease
2026 · Carolina S. E. Gadelha, Maria Teresa Terreri, et al. · Pediatric Research
PDF
Report of an Rsv Outbreak in a Long-term Care Facility for Older Adults in Vitória, Espírito Santo
2026 · Ana Paula Neves Burian, Clara Gonçalves Ruschi, et al. · The Brazilian Journal of Infectious Diseases
Social environment and services at the Special Immunobiological Reference Centers: epidemiological study, Minas Gerais, 2022-2024
2026 · Thaís Moreira Oliveira, Ana Catarina de Melo Araújo, et al. · Epidemiologia e Serviços de Saúde
Ambiente social e atendimentos do Centro de Referência para Imunobiológicos Especiais: estudo epidemiológico, Minas Gerais, 2022-2024
2026 · Thaís Moreira Oliveira, Ana Catarina de Melo Araújo, et al. · Epidemiologia e Serviços de Saúde
Impact of SARS-CoV-2 Vaccination on Disease Activity and Severity of COVID-19 Infection in Patients with Systemic Lupus Erythematosus: A Multicenter Cohort Study
2025 · Natália Sarzi Sartori, Ketty Lysie Libardi Lira Machado, et al. · Vaccines
Dados de replicação para: Ambiente social e atendimentos do Centro de Referência para Imunobiológicos Especiais de Minas Gerais, Brasil: um estudo epidemiológico
2025 · Oliveira, Thaís Moreira, Araújo, Ana Catarina de Melo, et al. · SciELO - Scientific Electronic Library Online Dataverse
Safety Profile of Vaccines Against Sars-cov-2 in Patients With Systemic Lupus Erythematosus: Data From Prospective Multicentric Study - Safer Study
2025 · Natália Sartori, Ketty Machado, et al. · The Journal of Rheumatology
Vaccination in patients with inborn errors of immunity or receiving immunosuppressive or biologic therapy: joint recommendations of the Brazilian Association of Allergy and Immunology and the Brazilian Immunization Society
2025 · Claudia França Cavalcante Valente, Ana Karolina Barreto Berselli Marinho, et al. · Arquivos de Asmas Alergia e Imunologia
PDF
Pos0572 Factors Associated With Vaccine Response After Covid Vaccine Booster in Patients With Autoimmune Diseases: Data From Multicentric Prospective Phase Iv Safer Study
2024 · K. Lysie Libardi Lira Machado, S.T. Miyamoto, et al. · Annals of the Rheumatic Diseases
Works count: 42
Citation count: 75
H-index: 5
I10-index: 1
Year
Topic
Type